The role of autoantibodies in bridging obesity, aging, and immunosenescence
Antibodies are essential to immune homeostasis due to their roles in neutralizing
pathogenic agents. However, failures in central and peripheral checkpoints that eliminate …
pathogenic agents. However, failures in central and peripheral checkpoints that eliminate …
[HTML][HTML] B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
R Flippot, M Teixeira, M Rey-Cardenas… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Immunotherapy profoundly changed the landscape of cancer therapy by providing long-
lasting responses in subsets of patients and is now the standard of care in several solid …
lasting responses in subsets of patients and is now the standard of care in several solid …
Innovations and trends in antibody repertoire analysis
DR Townsend, DM Towers, JJ Lavinder… - Current Opinion in …, 2024 - Elsevier
Highlights•Functional screens integrate with single cell BCR-sequencing and
transcriptomics.•Bottom-up and top-down MS enable comprehensive profiling of circulating …
transcriptomics.•Bottom-up and top-down MS enable comprehensive profiling of circulating …
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint …
S Soussan, G Pupier, I Cremer, PE Joubert… - Frontiers in …, 2024 - frontiersin.org
The intricate relationship between anti-tumor immunity and autoimmunity is a complex yet
crucial aspect of cancer biology. Tumor microenvironment often exhibits autoimmune …
crucial aspect of cancer biology. Tumor microenvironment often exhibits autoimmune …
The tumor-driven antibody-mediated immune response in cancer
P Paparoditis, Z Shulman - Current Opinion in Immunology, 2024 - Elsevier
Immune cells in the tumor microenvironment play a crucial role in cancer prognosis and
response to immunotherapy. Recent studies highlight the significance of tumor-infiltrating B …
response to immunotherapy. Recent studies highlight the significance of tumor-infiltrating B …
[HTML][HTML] Immune Repertoires in Various Dermatologic and Autoimmune Diseases
H Terhaar, V Jiminez, E Grant, C Collins, M Khass… - Genes, 2024 - mdpi.com
The immune repertoire (IR) is a term that defines the combined unique genetic
rearrangements of antigen receptors expressed by B and T lymphocytes. The IR determines …
rearrangements of antigen receptors expressed by B and T lymphocytes. The IR determines …
Survey of Changes in Absolute Lymphocyte Counts and Peripheral Immune Repertoire Diversity after External Beam Radiotherapy
SG Ellsworth, A Ross, KRY Shiue… - Radiation …, 2024 - meridian.allenpress.com
Radiation-induced lymphopenia (RIL) is associated with worse outcomes in patients with
multiple solid tumors. Hypofractionated radiation therapy (HFRT) reduces RIL compared …
multiple solid tumors. Hypofractionated radiation therapy (HFRT) reduces RIL compared …
[HTML][HTML] A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer
J Lou, Z Xiang, X Zhu, Y Fan, J Li, G Jin, S Cui… - Medicine, 2024 - journals.lww.com
This study aims to rigorously explore the potential causal relationships among gut
microbiota (GM), immune cells, and melanoma skin cancer among participants from Europe …
microbiota (GM), immune cells, and melanoma skin cancer among participants from Europe …
[HTML][HTML] B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma
Q Zhong, H Hao, S Li, Y Ning, H Li… - Journal for …, 2024 - pmc.ncbi.nlm.nih.gov
Background The role of B cells in antitumor immunity remains controversial, with studies
suggesting the protumor and antitumor activity. This controversy may be due to the …
suggesting the protumor and antitumor activity. This controversy may be due to the …
Insights for the immunotherapy in malignant melanoma: a new revolution
J Xuan, Z Gao, C Wei, J Gu - Clinical Cancer Bulletin, 2024 - Springer
Melanoma is highly malignant and mainly occurs in the skin. Melanoma was first used in
immunotherapy due to its high immunogenicity, which changed the therapeutic pattern of …
immunotherapy due to its high immunogenicity, which changed the therapeutic pattern of …